Find Academic Supervisors

Giuseppe CampianiView profile

Professor

• Medicinal Chemistry
• Pharmaceutical Chemistry
• Drug Design
• +7 more

Giuseppe Campiani is a Full Professor in the Department of Biotechnology, Chemistry and Pharmacy at the University of Siena. His research focuses on medicinal and pharmaceutical chemistry with applications across multiple therapeutic areas including infective diseases, neurodegenerative disorders, cancer, and parasitic diseases. His primary research interests include: Chemistry and biology of naturally-occurring and synthetic therapeutic molecules R&D for rare diseases and rational drug design Development of new synthetic methodologies Bioinformatics and structure-function relationships Metabolomic analyses for food traceability and authentication Professor Campiani's recent publications (2023-2025) reveal a strong emphasis on epigenetic drug discovery, particularly histone deacetylase (HDAC) inhibitors with applications in cancer, retinal diseases, and pulmonary fibrosis. His work also spans antiviral drug development (including for SARS-CoV-2 and monkeypox), natural product pharmacology, and food science applications. His research often bridges medicinal chemistry with practical therapeutic applications across diverse disease areas. He teaches courses in Pharmaceutical Chemistry and Technology, including Medicinal and Toxicological Chemistry and Laboratory in Drug Extraction and Synthesis through the 2025/2026 academic year.

Ellen ZhongView profile

Assistant Professor

• Machine Learning
• Computational Biology
• Structural Biology
• +7 more

Ellen Zhong is an Assistant Professor of Computer Science at Princeton University, leading the E.Z. Lab for Molecular Machine Learning. Her research bridges AI and structural biology, focusing on cryo-EM/cryo-ET data analysis for protein structure-dynamics characterization. Ph.D. in Computer Science from MIT (2022) Former DeepMind AlphaFold team member Ex-D. E. Shaw Research in drug discovery Key research domains include 3D Reconstruction , Protein Dynamics , Cryo-EM Heterogeneity , and Interpretability in Biomedical AI . She develops open-source tools like cryoDRGN-AI and cryoDRGN for high-throughput structural biology applications. Recent publications demonstrate AI-cryo-EM synergy (2025) and heterogeneous dataset benchmarking (NeurIPS 2024). Her work has received Princeton's Junior Faculty Award (2025) for excellence in research and teaching. Scientific Recognition : Junior Faculty Award, Princeton (2025) Notable Collaborations : AlphaFold3 development (Nature 2024) CryoDRGN-AI (Nature Methods 2025) Lab members include computational biologists and machine learning researchers working on generative modeling and biomedical imaging . Current projects span in situ proteomics , diffusion-based structural sampling , and multimodal biomedical data fusion .

• Neurobiology
• Molecular Pharmacology
• GPCR Signaling
• +3 more

Dr. Aliza Ehrlich is an Assistant Professor in the Department of Psychiatry at the University of California, San Francisco (UCSF) School of Medicine. Her research investigates the neurobiological mechanisms of G protein-coupled receptor (GPCR) activation, focusing on how compartmentalization of receptor signaling at membrane domains like the primary cilium affects neuromodulation and psychiatric disorders. She serves as Principal Investigator for NIH grant K01MH123757, which explores neuronal Gi-GPCR targeting to primary cilia and its impact on cAMP-mediated transcription. Her work bridges molecular neuroscience with clinical psychiatry, aiming to develop novel therapeutic approaches for neuropsychiatric conditions. Education: PhD in Neuroscience Her research spans multiple dimensions of GPCR biology, including opioid receptor dynamics , neuromodulatory pathways , and receptor localization at primary cilia . Key themes from her publications include autism-related protein convergence at cilia , sex-specific opioid receptor expression , and mesocorticolimbic network dysfunction in addiction models . She has contributed to understanding biased opioid receptor signaling , drug safety profiles , and GPCR compartmentalization in psychiatric disorders . Her recent work focuses on neurodevelopmental implications at the cilium , opioid receptor targeting mechanisms , and multiscale neural connectivity disruptions . Publications often integrate transgenic mouse models , neuroimaging , and molecular pharmacology approaches. Grants and Collaborations: NIH K01MH123757 (2020-2024) Co-authored 12 publications with collaborators across UCSF and other UC institutions Labs and Teams: Affiliated with von Zastrow and Kieffer laboratories, contributing to UCSF's neuroscience and psychiatric research ecosystems. Her work intersects with departments studying brain structure-function relationships , opioid pharmacology , and neurogenetics . Scientific Impact: Mentions in 48 publications (Mol Psychiatry 2018), 37 in PNAS (2016), and 33 in iScience (2019). Altmetric visibility includes 20 news outlets and 128 Mendeley readers for key works. Her research forms part of broader initiatives in GPCR signaling , opioid safety , and neuropsychiatric biomarkers .

• Neuro-ophthalmology
• Hereditary Retinal Diseases
• Ophthalmic Epidemiology
• +3 more

Byron L. Lam is a Professor of Ophthalmology at the Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine . He is also a member of the Graduate Program for the Department of Biochemistry and Molecular Biology with a secondary appointment in the field. Dr. Lam focuses on neuro-ophthalmology, hereditary retinal disease, and ophthalmic epidemiology through both clinical practice and research. Dr. Lam's research primarily involves gene therapy and translational clinical trials for conditions like retinitis pigmentosa, achromatopsia, and Stargardt disease. He has also developed innovative tools such as the Visual Light Sensitivity Questionnaire-8 (VLSQ-8) and the Bascom Palmer Light Discomfort Analyzer to quantify ocular light discomfort. His work in ophthalmic epidemiology explores how visual impairment impacts mortality through indirect pathways like activities of daily living. His recent publications from 2025 highlight advancements in retinal imaging (e.g., widefield OCT), XR (extended reality) applications in ophthalmology, and genetic testing outcomes for inherited retinal diseases. These articles also examine fundus autofluorescence and mitochondrial function in retinal health. Senior Achievement Award, American Academy of Ophthalmology Holder of the Robert Z. & Nancy J. Greene Chair in Ophthalmology Dr. Lam is the Medical Director of Clinical Research and Neuro-ophthalmology Service at Bascom Palmer, and Scientific Co-Director of the Adrienne Arsht Hope for Vision Retinal Degeneration Laboratory. He actively teaches residents and fellows, lectures medical students, and serves on PhD dissertation committees.

Katie MortlockView profile

Senior Lecturer

• Glaucoma research
• Diabetic retinopathy
• Visual electrophysiology
• +5 more

Dr Katie Mortlock is a Senior Lecturer on the Teaching and Scholarship pathway at Cardiff University's School of Optometry and Vision Sciences, where she serves as Academic Lead for Student Voice and Year 2 Lead. With over two decades of experience at the institution, she has progressed from Clinical Demonstrator (1996-1999) to her current part-time Senior Lecturer position (2024 onwards), maintaining continuous academic engagement since completing her undergraduate studies. Her educational foundation includes: PhD in Optometry and Vision Sciences (Cardiff University, 2001) BSc (Hons) in Optometry and Vision Sciences (Cardiff University, 1995) Registration with the General Optical Council (1996) Fellow of the Higher Education Academy (2016) Mortlock's expertise centers on clinical investigation of posterior segment eye diseases, particularly diabetic retinopathy and glaucoma. She has extensive experience with visual electrophysiology techniques including photopic negative response and S-cone electroretinogram (ERG), as well as structural analysis using optical coherence tomography (OCT). Her research bridges clinical practice with scientific investigation to understand retinal function and optic nerve changes in ocular disease. Analysis of her publication record reveals consistent scholarly activity from 2001-2022, with recent work focusing on advanced OCT imaging for glaucoma diagnostics and progression monitoring. Her research demonstrates evolution from fundamental electrophysiological investigations to sophisticated structural imaging applications, particularly using 1050nm wavelength OCT for deeper tissue penetration in optic nerve head analysis. Her professional recognition includes: Fellow of the Higher Education Academy (2016) As an educator, Mortlock co-developed the Preliminary Year program in 2013 and currently leads two second-year modules. She regularly supervises undergraduate and postgraduate projects and has held leadership positions including joint Year Lead (2013-2017) and Year 2 Lead (since 2022). Her additional roles include Personal Tutor, Learning Central Domain Administrator, and membership on the UG Teaching Management team. Mortlock has collaborated with Cardiff's Optic Nerve Head Research Group, working with Dr Julie Albon, Prof Rachel North, and Prof James Morgan. Her OCT-based research has provided valuable insights into lamina cribrosa structure in glaucoma patients, contributing to understanding disease mechanisms and progression.

• Vision Science
• Optometry
• Psychophysics
• +5 more

Tony Redmond is a Reader in Vision Science at Cardiff University's School of Optometry and Vision Sciences, where he has progressed from Lecturer (2012) to Senior Lecturer (2015) before achieving his current position in 2021. His research centers on understanding the functional architecture of the visual system and its alterations in neurodegenerative disorders, particularly glaucoma and macular degeneration. Dr. Redmond's primary research interests include basic and clinical psychophysics, spatial and temporal summation, perimetry, and the development of clinical diagnostic tools. His laboratory employs a multidisciplinary approach combining psychophysics, electrophysiology, retinal imaging, and fMRI to investigate visual system function. A significant focus of his work examines how spatial summation changes in glaucoma and aging, with implications for improving visual field testing accuracy. His publication record shows consistent output in high-impact vision science journals, with research trends emphasizing glaucoma diagnostics, perimetry techniques, spatial summation analysis, and retinal imaging . Recent work increasingly incorporates advanced methodologies like gaze-contingent perimetry and adaptive optics imaging. MRC Developmental Pathway Funding Scheme (DPFS) - £1.82 million (2021-2025) Fight for Sight PhD Studentship (£100,000) Macular Society PhD Studentship (£100,000) George Giles Prize for Postgraduate Research Excellence (2010) World Glaucoma Congress poster presentation award (2nd place, 2009) Dr. Redmond actively supervises postgraduate research, currently mentoring Caitlín Campbell (PhD, 2026) and having previously guided 12 students to completion. He serves as Principal Investigator on the REVAMP Study, a UK-wide multi-site investigation developing novel visual field tests for glaucoma detection. His research collaborations span multiple institutions including Moorfields Eye Hospital, UCL Institute of Ophthalmology, and Ulster University.

• Cardiovascular Disease
• Atherosclerosis
• Neuroimaging
• +6 more

Marit Herder serves as Associate Professor II at UiT The Arctic University of Norway, affiliated with both the Medical Imaging Research Group and Brain and Circulation Research Group . She maintains a 20% appointment as a university lecturer in the Radiology Department while conducting population-based research primarily through the Tromsø Study cohort. Her work bridges neuroimaging, cardiovascular epidemiology, and cerebrovascular disease mechanisms. Her research focuses on cardiovascular risk factors for atherosclerosis progression , particularly in carotid arteries, and their neurological consequences including intracranial aneurysms, Alzheimer's disease, and cognitive decline. Key methodologies involve magnetic resonance angiography and longitudinal analysis of population cohorts. Major themes include the interplay between metabolic syndrome, renal function, and vascular pathology, with emphasis on how subclinical disease manifests in brain structure and function. Analysis of her 15 most recent publications reveals consistent focus on population-based neurovascular epidemiology , with nearly all studies leveraging the Tromsø Study dataset. Her work demonstrates methodological rigor in applying advanced imaging techniques to large cohorts, establishing connections between vascular pathology and neurological outcomes. The research trajectory shows increasing sophistication in multimodal imaging analysis while maintaining clinical epidemiological relevance. Her collaborative network spans neurology, radiology, and cardiology departments, with frequent co-authorship involving Tromsø Study investigators. Current projects include the Carotid Atherosclerosis initiative and ongoing analysis of the Tromsø cohort's neuroimaging data. She maintains active clinical-academic engagement through the Medical Imaging Research Group's facilities in Tromsø.

Imam UddinView profile

Assistant Professor

• Molecular Imaging
• Optical Imaging
• Optical Coherence Tomography
• +8 more

Dr. Imam Uddin is an Assistant Professor in the Department of Ophthalmology and Visual Sciences and the Department of Biomedical Engineering at Vanderbilt University School of Medicine. His research focuses on developing innovative molecular imaging technologies for early disease detection and treatment in ophthalmology. Dr. Uddin earned his Ph.D. in Applied Material Sciences from Kochi University, Japan, following earlier degrees in Chemistry from Jahangirnagar University in Bangladesh. Dr. Uddin's research centers on molecular imaging technologies including optical imaging, optical coherence tomography (OCT), and nanoscale engineering. His laboratory develops approaches for early detection and treatment of retinal diseases such as diabetic retinopathy (DR), age-related macular degeneration (AMD), retinopathy of prematurity (ROP), and retinal vein occlusion (RVO). His team has pioneered innovative techniques like the HYPOX-4 fluorescence imaging probe for detecting retinal hypoxia in living animals and hairpin-DNA functionalized gold nanoparticles for imaging disease-relevant biomarkers. These technologies enable researchers to track critical hallmarks of retinal disease and understand how retinopathies develop, potentially aiding physicians in determining optimal therapeutic intervention timing. Analysis of Dr. Uddin's recent publications reveals a strong focus on molecular imaging of retinal diseases, particularly using nanotechnology-based approaches. His work spans from basic chemical synthesis of molecular probes to preclinical applications in animal models of retinal disease. A significant portion of his research investigates hypoxia detection and monitoring of neovascularization processes that lead to vision loss. His laboratory has developed patented technologies including probes for targeted visualization of NLRP3 inflammasomes and nanogold-DNA bioconjugates. Reeves Foundation Grant 2022-2023 ($47,100) for an OptoDrum automated optokinetic measurement system American Diabetes Association Innovative Basic Science Award 2022 International Retinal Research Foundation (IRRF) pilot Grant for AMD research BrightFocus Foundation Macular Degeneration Award of $200,000 (2019-2021) National Eye Institute R01 grants totaling over $3.7 million Dr. Uddin serves as Principal Investigator on multiple significant research grants, including NIH R01 funding for in vivo molecular imaging of retinal vascular disease. His laboratory actively mentors students and postdoctoral researchers, with recent publications featuring trainees as first authors. Dr. Uddin is also serving as Executive Guest Editor for a special issue on "Molecular Imaging of the Retina" in Experimental Eye Research, with submissions due May 31, 2025. The Uddin Laboratory operates state-of-the-art imaging facilities including OCT systems and optical imaging equipment. The lab collaborates extensively with the Vanderbilt Eye Institute and other research centers at Vanderbilt, particularly in developing technologies that bridge engineering, chemistry, and ophthalmology to address unmet clinical needs in retinal disease diagnosis and treatment.

Stephen A. BurnsView profile

Professor

• Retinal Imaging
• Retinal Function
• Vision Science
• +7 more

Stephen A. Burns serves as Professor and Associate Dean for Graduate Programs at Indiana University School of Optometry, where he maintains an active research laboratory and holds endorsement to chair PhD committees. His work bridges the fields of vision science, optical engineering, and clinical ophthalmology with a focus on retinal structure and function. Dr. Burns' research interests span retinal imaging, adaptive optics technology development, and the study of cone photoreceptors in health and disease. His laboratory specializes in developing state-of-the-art optical technology based on Adaptive Optics to investigate retinal structure and function, with particular emphasis on how aging and disease impact the retina. Key research areas include diabetic retinopathy, vascular structure and function, and cone photoreceptor analysis. His recent publications demonstrate a strong focus on advancing retinal imaging techniques, particularly through adaptive optics, with applications for understanding diabetic retinopathy progression and vascular changes. The research shows consistent interdisciplinary collaboration across optics, engineering, and clinical ophthalmology, with emphasis on translating technological advances into clinical applications for early disease detection. Tillyer Medal from Optical Society of America Fellow of The Optical Society of America (since 1993) Dr. Burns has served in significant editorial and review capacities, including as past editor of the Journal of the Optical Society of America and service on the Visual Science C Study Section. His laboratory receives support from the National Eye Institute for research on diabetic retinopathy, developing precise techniques for measuring vascular structure and blood velocity in the living human retina. The Burns Lab maintains active research programs in photoreceptor imaging, vascular structure and function, and the development of adaptive optics technologies for retinal imaging, with ongoing investigations into early changes in diabetic retinopathy and the relationship between vascular changes and photoreceptor health.

• Mucosal Immunology
• Anatomy of the Eye
• Cell Biology of the Pancreas
• +3 more

Eugenio Bertelli is an Associate Professor of Human Anatomy at the University of Siena since 2002. He holds editorial board roles at J Histochem Cytochem , J Mol Histol , and Anat Cell Biol . His teaching spans Human Anatomy courses for Biological Sciences, Pharmacy, Ophthalmology, and Surgical Specialties. Bertelli’s research focuses on mucosal immunology, pancreatic cell biology, ocular anatomy, and vascular anatomy. Key contributions include studies on pancreatic islet-ductal interactions, M-cell antigen transport, and Salmonella-induced immune responses. His work bridges histology, clinical anatomy, and immunopathology. Recent publications explore anatomical variations, hepatic steatosis mechanisms, and epiretinal membrane biology. He has authored textbooks like Atlante Fotografico Anatomia Macroscopica . Education: MD, University of Siena (1988) PhD in Morphological Sciences (1996) Postdoctoral Fellowships at Université de Montréal (1995-1997) and University of Siena (1997-1998) Research Interests: Mucosal Immunology: Focus on M-cells, antigen transport, and gut immunity Pancreatic Cell Biology: Endocrine-exocrine interactions, islet-ductal relationships Ocular Anatomy: Retinal pathologies, epiretinal membrane composition Vascular Anatomical Variations: Clinical implications in surgery and imaging Recent Research Trends: His articles emphasize anatomical variation documentation (e.g., temporal arteries, ethmoidal foramina), experimental models of metabolic disease (liver steatosis), and translational studies on epiretinal membrane proteins. Collaborations include investigations into Salmonella pathogenesis and lymphatic dysfunction in lymphedema. Professional Activities: Active in anatomical education, editorial work, and clinical-anatomical interface research. No grants/advising details explicitly reported in sources.

Esther Biswas-FissView profile

Professor

• Genetic Variation
• Protein Structure/Function
• Inherited Retinal Degeneration
• +3 more

Esther Biswas-Fiss is a Professor and Chair in the Department of Medical & Molecular Sciences at the University of Delaware's College of Health Sciences. Her research focuses on genetic variations and their impact on protein function, particularly in inherited retinal diseases and viral oncogenesis. She holds a Ph.D. in Molecular Bioscience from Rutgers University, an M.S. in Biochemistry from the University of Maryland, and a B.S. in Chemistry from the University of Washington. Her laboratory investigates the molecular genetics of inherited macular degeneration, aiming to correlate genetic mutations with disease phenotypes. She also explores the role of genetic variation in HPV-mediated oncogenesis. Key projects include studying ABCA4 protein structure-function relationships and viral DNA replication mechanisms. Recent publications highlight advancements in ABCA4 variant analysis, tick-borne pathogen surveillance, and HPV replication mechanisms. She has pioneered methods like virus-like particles for assessing genetic variant pathogenicity and employs computational tools for in silico modeling of protein interactions. Her work bridges basic molecular research with clinical applications in retinal disease and infectious oncology. Dr. Biswas-Fiss leads the Medical & Molecular Sciences department, overseeing undergraduate and graduate programs in applied molecular biology, medical diagnostics, and biotechnology. Her interdisciplinary approach fosters innovation in both education and translational research.

• Protein Folding
• Membrane Biophysics
• Neurodegenerative Diseases
• +3 more

Ralf Langen serves as Professor of Physiology & Neuroscience at the University of Southern California's Keck School of Medicine. He directs both the Protein Structure Center at the Zilkha Neurogenetic Institute and the Ph.D. Program in Medical Physiology, while co-directing the Ph.D. Program in Medical Biophysics. His academic leadership spans multiple interdisciplinary programs including the Programs in Biomedical and Biological Sciences and the PEW Scholar initiative. Langen's research centers on protein folding and misfolding dynamics, with specific emphasis on membrane-mediated processes. His laboratory investigates how proteins regulate membrane structure/function through composition, fluidity, and curvature modulation, and conversely how membranes influence protein conformation. A major focus involves pathological protein misfolding in neurodegenerative diseases like Huntington's and Parkinson's, with particular attention to huntingtin exon-1 aggregation mechanisms. His work employs advanced biophysical techniques including site-directed spin labeling, EPR spectroscopy, and computational modeling to resolve structural dynamics at membrane interfaces. Analysis of his publication record reveals consistent contributions to understanding membrane-protein interactions in amyloid formation. His recent work demonstrates how membrane environments alter aggregation pathways, generate toxic oligomers, and influence strain-specific pathology in polyglutamine disorders. Key findings include elucidating the role of post-translational modifications like lysine acetylation in membrane binding, characterizing conformational switching in huntingtin variants, and developing small-molecule inhibitors targeting aggregation. No scientific awards explicitly listed in source material As director of USC's Medical Physiology Ph.D. program and co-director of the Medical Biophysics program, Langen oversees graduate training while maintaining active research mentorship. His laboratory receives funding for structural studies of neurodegenerative disease mechanisms, though specific grants aren't detailed in the source text. The Protein Structure Center under his direction provides critical infrastructure for membrane protein research. Langen's primary research facility operates within the Zilkha Neurogenetic Institute, where his Protein Structure Center specializes in membrane-protein interactions. The center integrates biophysical, biochemical, and computational approaches to study conformational dynamics in disease-related proteins, with particular expertise in spin-labeling techniques for membrane-embedded systems.

Eberhart ZrennerView profile

Professor

• Retinal Physiology
• Ophthalmogenetics
• Retinal Prosthesis
• +3 more

Prof. Eberhart Zrenner is a Senior Professor of Ophthalmology at the University of Tübingen's Institute for Ophthalmic Research, part of the Centre for Ophthalmology. His research focuses on retinal physiology/pathophysiology, neuro-ophthalmology, and retinal prosthesis development. He pioneered the electronic subretinal prosthesis and led the first gene therapy trial for achromatopsia. He holds two honorary doctoral degrees and has published over 600 peer-reviewed papers with an h-index of 86. Education: MD from Technical University of Munich (1972), followed by postdoctoral work at the Max-Planck-Institute and NIH. Founded the Institute for Ophthalmic Research (1989) and directed it until 2018. Current roles include leadership in the Werner Reichardt Centre for Integrative Neuroscience. Research interests span inherited retinal dystrophies, gene therapy, and clinical diagnostics. Key innovations include the 1600-pixel subretinal prosthesis and gene therapy applications. His lab collaborates with molecular genetics and clinical teams to advance therapeutic strategies. Awards and grants: Multiple national/international grants, 66 patents on ophthalmic devices, and leadership in EU-funded trials. His work bridges basic science and clinical applications, emphasizing patient care and translational research.

Rune BrautasetView profile

Professor

• Visual Neuroscience
• Ophthalmology
• Clinical Medicine
• +3 more

Rune Brautaset is a Professor at Karolinska Institutet's Department of Clinical Neuroscience, leading the Visual Neuroscience research group. His roles include Head of the Division of Eye and Vision and former Head of Undergraduate Education in Clinical Neuroscience. He holds a PhD in Optometry and Neuroscience from the University of Manchester and has been pivotal in establishing optometric education and research at KI. His research focuses on visual neuroscience, eye structure-function relationships, and neurodegenerative diseases. He has supervised 5 doctoral students and received pedagogical awards in 2006 and 2015. His work combines clinical optometry with advanced imaging techniques like OCT to study conditions such as glaucoma, multiple sclerosis, and Alzheimer's. Education: BSc (Hon) in Optometry (UMIST, 1998), MPhil (UMIST, 1999), PhD (UMIST, 2003). Professional roles include leadership in education committees and national research groups. His interdisciplinary approach bridges clinical practice and research, addressing both fundamental and applied aspects of vision science.

Anahit HovhannisyanView profile

Lecturer

• Neuroscience
• Neurophysiology
• Biophysics
• +7 more

Dr. Anahit Hovhannisyan is a Lecturer in the Biology Department at California State University, Fresno, within the College of Science and Mathematics. She holds a Ph.D. in Neural and Behavioural Sciences from the University of Tübingen, Germany, and prior degrees from Yerevan State University. Her research focuses on neurodegeneration, neural plasticity, and retinal biology, with expertise in imaging techniques like fluorescent microscopy and 3D confocal imaging. She has contributed to projects on retinal structure-function relationships, oligodendrocyte precursor cell responses, and synaptic adaptations in neurodegenerative contexts. Education: B.S. and M.S. in Biophysics, Yerevan State University Ph.D., Neural and Behavioural Sciences, University of Tübingen Teaching: Teaches courses including Human Anatomy & Physiology, Neurophysiology, and Evidence-Based Decision Making. Implements active learning methodologies. Her research interests span biophysics, animal behavior, and neuroinformatics, with a focus on interdisciplinary approaches to understanding neural systems. She has received awards such as the ZEISS Scientific Poster Award and DFG stipends, and is involved in teaching innovation projects like NSF ALIS-XR and Small Changes, Big Rewards initiatives. Dr. Hovhannisyan’s students have contributed to over 40 research projects and developed educational materials for the Fresno Discovery Center. She actively engages in professional development, including training programs like Scorecard and QR1.